We are live on ! Find out more
MA

MCF Advisors Portfolio holdings

AUM $2.8B
1-Year Est. Return 19.11%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+19.11%
3 Year Est. Return
+50.23%
5 Year Est. Return
+49.47%
10 Year Est. Return
+152.91%
AUM
$539M
AUM Growth
+$29.4M
Cap. Flow
+$9.64M
Cap. Flow %
1.79%
Top 10 Hldgs %
73.13%
Holding
537
New
22
Increased
115
Reduced
75
Closed
44

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.81%
2 Financials 3.14%
3 Consumer Staples 1.21%
4 Energy 1.14%
5 Technology 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBAC icon
301
SBA Communications
SBAC
$19.4B
$19K ﹤0.01%
114
IBDL
302
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$19K ﹤0.01%
764
EMB icon
303
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.2B
$18K ﹤0.01%
156
-126
-45% -$14.6K
HOV icon
304
Hovnanian Enterprises
HOV
$705M
$18K ﹤0.01%
217
MDLZ icon
305
Mondelez International
MDLZ
$79.3B
$18K ﹤0.01%
414
+2
+0.5% +$84
ELV icon
306
Elevance Health
ELV
$90.6B
$17K ﹤0.01%
74
FENY icon
307
Fidelity MSCI Energy Index ETF
FENY
$2.21B
$17K ﹤0.01%
+866
New +$16.5K
SNPS icon
308
Synopsys
SNPS
$70.5B
$17K ﹤0.01%
200
COST icon
309
Costco
COST
$400B
$16K ﹤0.01%
85
+27
+47% +$4.66K
TTE icon
310
TotalEnergies
TTE
$206B
$16K ﹤0.01%
298
CNX icon
311
CNX Resources
CNX
$5.24B
$15K ﹤0.01%
1,002
-200
-17% -$2.76K
FBT icon
312
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
$15K ﹤0.01%
120
HCR
313
DELISTED
Hi-Crush Inc. Common Stock
HCR
$15K ﹤0.01%
1,379
AKBA icon
314
Akebia Therapeutics
AKBA
$250M
$14K ﹤0.01%
913
ANIK icon
315
Anika Therapeutics
ANIK
$280M
$13K ﹤0.01%
250
FXH icon
316
First Trust Health Care AlphaDEX Fund
FXH
$1.14B
$13K ﹤0.01%
180
ORA icon
317
Ormat Technologies
ORA
$5.61B
$13K ﹤0.01%
200
TRV icon
318
Travelers Companies
TRV
$78.8B
$13K ﹤0.01%
99
LUMO
319
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$13K ﹤0.01%
183
IVTY
320
DELISTED
Invuity, Inc
IVTY
$13K ﹤0.01%
2,087
BEN icon
321
Franklin Templeton
BEN
$16.9B
$12K ﹤0.01%
267
EXC icon
322
Exelon
EXC
$43.5B
$12K ﹤0.01%
425
+3
+0.7% +$86
FXG icon
323
First Trust Consumer Staples AlphaDEX Fund
FXG
$220M
$12K ﹤0.01%
240
GM icon
324
General Motors
GM
$74.9B
$12K ﹤0.01%
295
MTH icon
325
Meritage Homes
MTH
$4.29B
$12K ﹤0.01%
472

Similar funds

MCF Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, MCF Advisors held 537 positions worth $539M, up 5.8% from $510M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

MCF Advisors's Q4 2017 filing shows 22 new, 115 increased, 75 reduced and 44 closed positions. Its largest new stake was Centene: 4,392 shares worth $222K. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $1.29M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, up from 90% a quarter earlier, followed by Financials and Consumer Staples.

  • MCF Advisors's largest Q4 2017 buy was Centene: 4,392 shares worth $222K.
  • MCF Advisors added most to iShares Core US Aggregate Bond ETF in Q4 2017, an estimated $2.89M increase.
  • MCF Advisors's biggest Q4 2017 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.29M.
  • MCF Advisors fully exited Insulet in Q4 2017, selling an estimated $122K.
  • MCF Advisors's ten largest holdings make up 73% of its $539M portfolio in Q4 2017.
  • MCF Advisors opened 22 new positions and closed 44 in Q4 2017.
  • MCF Advisors's portfolio value rose 5.8% quarter-over-quarter to $539M.

Based on MCF Advisors's 13F filing for Q4 2017, filed 6 Feb 2018.